Overview

A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Primary to evaluate the 1-year treatment failure rate of two sequential chemotherapy regimens: 1. weekly docetaxel plus cisplatin followed by gemcitabine and 2. gemcitabine plus cisplatin followed by weekly docetaxel. Study design:Prospective, multi-center, open-labelled, randomized phase II study.

Phase:

Phase 2

Details

Lead Sponsor:

Far Eastern Memorial Hospital

Treatments:

Cisplatin
Docetaxel
Gemcitabine